FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2003098071> ?p ?o ?g. }

• W2003098071 endingPage "230" @default.
• W2003098071 startingPage "217" @default.
• W2003098071 abstract "Huntington's disease (HD), a basal ganglia disorder, is characterized not only by a spectrum of motor deficits, but also by emotional, cognitive and psychiatric manifestations. Cognitive impairment is one of the serious manifestations of this disease in the later stage of life. Although there is currently no cure for HD, there has been a surge of clinical trials involving patients with HD over the past 5 years. However, cognitive measures have generally been lacking from these trials. The beneficial effect of antidepressants in HD has been suggested in recent clinical trials. However, their mechanism of action is still not clear. Therefore, this study was designed to elucidate and compare the mechanistic role of different classes of antidepressants (sertraline, venlafaxine, imipramine and trazodone) against 3-nitropropionic acid (3-NP)-induced cognitive impairment, oxidative stress (glutathione) and mitochondrial dysfunction in rat hippocampus. Systemic treatment with 3-NP (10 mg/kg for 14 days) significantly impaired memory performance (both in the Morris water maze and elevated plus maze escape retention test), oxidative defence (glutathione redox status) and mitochondrial enzyme complex activities in rat hippocampus. Sertraline, venlafaxine, imipramine and trazodone treatments significantly improved performance in both cognitive tasks and glutathione redox status, and restored mitochondrial enzyme complex activities, as compared with the 3-NP treated group. L-arginine (50 mg/kg) pretreatment for 14 days together with a subeffective dose of sertraline (10 mg/kg), venlafaxine (10 mg/kg), imipramine (10 mg/kg) or trazodone (10 mg/kg) partially attenuated their protective effects. Further, G-nitro-L-Arginine-Methyl Ester (10 mg/kg) pretreatment together with subeffective dose of sertraline (10 mg/kg), venlafaxine (10 mg/kg), imipramine (10 mg/kg) and trazodone (10 mg/kg) significantly enhanced their efficacy. The results of this study suggest that nitric oxide modulation is involved in their protective effect of antidepressants against 3-NP induced cognitive dysfunction in rats." @default.
• W2003098071 created "2016-06-24" @default.
• W2003098071 creator A5020718241 @default.
• W2003098071 creator A5031501378 @default.
• W2003098071 creator A5047004036 @default.
• W2003098071 date "2010-05-01" @default.
• W2003098071 modified "2023-10-02" @default.
• W2003098071 title "Nitric oxide mechanism in the protective effect of antidepressants against 3-nitropropionic acid-induced cognitive deficit, glutathione and mitochondrial alterations in animal model of Huntington's disease" @default.
• W2003098071 cites W1017951118 @default.
• W2003098071 cites W1408977967 @default.
• W2003098071 cites W1506043065 @default.
• W2003098071 cites W1563847798 @default.
• W2003098071 cites W1581414347 @default.
• W2003098071 cites W1588570886 @default.
• W2003098071 cites W1923027407 @default.
• W2003098071 cites W1965392554 @default.
• W2003098071 cites W1969805452 @default.
• W2003098071 cites W1971884195 @default.
• W2003098071 cites W1972673776 @default.
• W2003098071 cites W1974431794 @default.
• W2003098071 cites W1978183586 @default.
• W2003098071 cites W1980898362 @default.
• W2003098071 cites W1983995842 @default.
• W2003098071 cites W1984632761 @default.
• W2003098071 cites W1990881177 @default.
• W2003098071 cites W1992944184 @default.
• W2003098071 cites W1993943341 @default.
• W2003098071 cites W1995946351 @default.
• W2003098071 cites W2006370393 @default.
• W2003098071 cites W2006399152 @default.
• W2003098071 cites W2009351346 @default.
• W2003098071 cites W2010373031 @default.
• W2003098071 cites W2010911467 @default.
• W2003098071 cites W2015224507 @default.
• W2003098071 cites W2018591060 @default.
• W2003098071 cites W2026311096 @default.
• W2003098071 cites W2029574067 @default.
• W2003098071 cites W2039237464 @default.
• W2003098071 cites W2039436311 @default.
• W2003098071 cites W2043142929 @default.
• W2003098071 cites W2048465410 @default.
• W2003098071 cites W2048513018 @default.
• W2003098071 cites W2054273322 @default.
• W2003098071 cites W2058327425 @default.
• W2003098071 cites W2068113532 @default.
• W2003098071 cites W2070034702 @default.
• W2003098071 cites W2070554778 @default.
• W2003098071 cites W2072780035 @default.
• W2003098071 cites W2074595259 @default.
• W2003098071 cites W2077223577 @default.
• W2003098071 cites W2081137194 @default.
• W2003098071 cites W2085638646 @default.
• W2003098071 cites W2097828712 @default.
• W2003098071 cites W2103477251 @default.
• W2003098071 cites W2117744574 @default.
• W2003098071 cites W2126578788 @default.
• W2003098071 cites W2133565799 @default.
• W2003098071 cites W2135189917 @default.
• W2003098071 cites W2140237162 @default.
• W2003098071 cites W2147532876 @default.
• W2003098071 cites W2152165298 @default.
• W2003098071 cites W2153353641 @default.
• W2003098071 cites W2153881504 @default.
• W2003098071 cites W2169714384 @default.
• W2003098071 cites W796411738 @default.
• W2003098071 doi "https://doi.org/10.1097/fbp.0b013e32833a5bf4" @default.
• W2003098071 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20480544" @default.
• W2003098071 hasPublicationYear "2010" @default.
• W2003098071 type Work @default.
• W2003098071 sameAs 2003098071 @default.
• W2003098071 citedByCount "38" @default.
• W2003098071 countsByYear W20030980712012 @default.
• W2003098071 countsByYear W20030980712013 @default.
• W2003098071 countsByYear W20030980712014 @default.
• W2003098071 countsByYear W20030980712015 @default.
• W2003098071 countsByYear W20030980712016 @default.
• W2003098071 countsByYear W20030980712017 @default.
• W2003098071 countsByYear W20030980712019 @default.
• W2003098071 countsByYear W20030980712020 @default.
• W2003098071 countsByYear W20030980712021 @default.
• W2003098071 countsByYear W20030980712022 @default.
• W2003098071 countsByYear W20030980712023 @default.
• W2003098071 crossrefType "journal-article" @default.
• W2003098071 hasAuthorship W2003098071A5020718241 @default.
• W2003098071 hasAuthorship W2003098071A5031501378 @default.
• W2003098071 hasAuthorship W2003098071A5047004036 @default.
• W2003098071 hasConcept C126322002 @default.
• W2003098071 hasConcept C15744967 @default.
• W2003098071 hasConcept C181199279 @default.
• W2003098071 hasConcept C185592680 @default.
• W2003098071 hasConcept C2776151105 @default.
• W2003098071 hasConcept C2776466888 @default.
• W2003098071 hasConcept C2779177272 @default.
• W2003098071 hasConcept C2780980600 @default.
• W2003098071 hasConcept C2781161787 @default.
• W2003098071 hasConcept C44752575 @default.
• W2003098071 hasConcept C538909803 @default.
• W2003098071 hasConcept C55493867 @default.

• next